I agree that this site is using cookies. You can find further informations here.
X
Hovinga, J. A. Kremer
325  results:
Search for persons X
?
1

THE DYNAMIC RANGE OF IMMUNOASSAYS FOR HEPARIN-INDUCED THROM..:

Nilius, H. ; Naas, S. ; Nakas, C....
Clinica Chimica Acta.  558 (2024)  - p. 118428 , 2024
Link: https://doi.org/10.1016/..
 
?
2

S294: LONG-TERM SAFETY AND EFFICACY OF CAPLACIZUMAB FOR ACQ..:

Scully, M. ; de la Rubia, J. ; Pavenski, K....
HemaSphere.  6 (2022)  - p. 195-196 , 2022
Link: https://doi.org/10.1097/..
 
?
3

Caplacizumab induces fast and durable platelet count respon..:

Kaynar, L. ; Coppo, P. ; Scully, M....
Hematology, Transfusion and Cell Therapy.  42 (2020)  - p. 62-63 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Safety of caplacizumab in patients without documented sever..:

Besisik, S. ; Rubia, J. De La ; Peyvandi, F....
Hematology, Transfusion and Cell Therapy.  42 (2020)  - p. 62 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Résultats d'efficacité d'une analyse intégrée des essais cl..:

Coppo, P. ; Scully, M. ; Cataland, S....
La Revue de Médecine Interne.  40 (2019)  - p. A76-A77 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Résultats de l'essai de phase III HERCULES – Essai contrôlé..:

Scully, M. ; Cataland, S. ; Peyvandi, F....
La Revue de Médecine Interne.  39 (2018)  - p. A61-A62 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Pathophysiology of thrombotic thrombocytopenic purpura and ..:

Kremer Hovinga, J. A. ; Heeb, S. R. ; Skowronska, M..
Journal of Thrombosis and Haemostasis.  16 (2018)  4 - p. 618-629 , 2018
Link: https://doi.org/10.1111/..
 
?
8

Caplacizumab reduces the frequency of major thromboembolic ..:

Peyvandi, F. ; Scully, M. ; Kremer Hovinga, J.A....
Journal of Thrombosis and Haemostasis.  15 (2017)  7 - p. 1448-1452 , 2017
Link: https://doi.org/10.1111/..
 
?
9

Consensus on the standardization of terminology in thrombot..:

Scully, M. ; Cataland, S. ; Coppo, P....
Journal of Thrombosis and Haemostasis.  15 (2017)  2 - p. 312-322 , 2017
Link: https://doi.org/10.1111/..
 
?
10

High prevalence of hereditary thrombotic thrombocytopenic p..:

von Krogh, A. S. ; Quist-Paulsen, P. ; Waage, A....
Journal of Thrombosis and Haemostasis.  14 (2016)  1 - p. 73-82 , 2016
Link: https://doi.org/10.1111/..
 
?
11

Establishment of the WHO 1st International Standard ADAMTS1..:

Hubbard, A. R. ; Heath, A. B. ; Kremer Hovinga, J. A..
Journal of Thrombosis and Haemostasis.  13 (2015)  6 - p. 1151-1153 , 2015
Link: https://doi.org/10.1111/..
 
?
12

Impaired DNase1-mediated degradation of neutrophil extracel..:

Jiménez-Alcázar, M. ; Napirei, M. ; Panda, R....
Journal of Thrombosis and Haemostasis.  13 (2015)  5 - p. 732-742 , 2015
Link: https://doi.org/10.1111/..
 
?
13

Von Willebrand factor binds to surface-bound C1q in vitro:

Kölm, R. ; Schaller, M. ; Vanhecke, D....
Molecular Immunology.  56 (2013)  3 - p. 251-252 , 2013
Link: https://doi.org/10.1016/..
 
?
14

Humoral immune response to ADAMTS13 in acquired thrombotic ..:

POS, W. ; LUKEN, B. M. ; SORVILLO, N...
Journal of Thrombosis and Haemostasis.  9 (2011)  7 - p. 1285-1291 , 2011
Link: https://doi.org/10.1111/..
 
?
15

Recombinant ADAMTS13 normalizes von Willebrand factor-cleav..:

PLAIMAUER, B. ; KREMER HOVINGA, J. A. ; JUNO, C....
Journal of Thrombosis and Haemostasis.  9 (2011)  5 - p. 936-944 , 2011
Link: https://doi.org/10.1111/..
 
1-15